Abstract
Superficial bleeding in patients with malignant disease is a distressing symptom, which is often difficult to control. The following is a case study outlining the use of Sucralfate, an oral cytoprotective agent, used topically in a patient with colo-rectal cancer. The treatment resulted in control of bleeding, less localized pain and more freedom and independence for the patient.
This is a preview of subscription content, log in via an institution to check access.
References
Campieri M, Gionchetti P, Belluzzi A, Brignola C, Tampieri M, et al (1991) Sucralfate, 5-aminosalicylic acid and placebo enemas in the treatment of distal ulcerative colitis. J Gastroenterol Hepatol 3:41–44
Drugdex editorial staff (1991) Topical Sucralfate use in woun healing. In: Gelman CR, Rumack BH (eds) Drugdex Information System. Micromedex Inc, Denver, Colo
Kochhar R, Sharma SC, Gupta BD, Mehta SK (1988) Rectal Sucrlfate in radiation proctitis. Lancet II:400
Kochhar R, Patel F, Dhar A, et al (1991) Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral Sulfasalazine plus rectal steroids versus rectal Sucralfate. Dig Dis Sci 36:103–107
Regnard C (1991) Control of bleeding in advanced cancer. Lancet 337:974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farncombe, M. Management of bleeding in a patient with colorectal cancer: a case study. Support Care Cancer 1, 159–160 (1993). https://doi.org/10.1007/BF00366064
Issue Date:
DOI: https://doi.org/10.1007/BF00366064